Basic and clinical research of GPHB5 on energy metabolism

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000039136

Enrollment

Unknown

Registered

2020-10-18

Start date

2020-11-01

Completion date

Unknown

Last updated

2021-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity

Interventions

male:N/A

female:N/A

Eligibility

Sex/Gender

All

Age

21 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Group of healthy adults aged 21 to 90 years; 2. Healthy lifestyle, regular diet and sleep; 3. No medications have been taken in the past three months; 4. No acute or chronic diseases; 5. Ability to understand and sign the informed consent form independently.

Exclusion criteria

Exclusion criteria: 1. Perform castration; 2. Have taken sex hormone-related drugs in the past 3 months; 3. Patients who take drugs or long-term alcoholism that affect the evaluation of the test results.

Design outcomes

Primary

Measure	Time frame
GPHB5;testosterone;	—

Secondary

Measure	Time frame
17 ß estradiol;	—

Countries

China

Contacts

Public ContactAllan Z. Zhao

Guangdong University of Technology

azzhao@gdut.edu.cn+86 18027330698

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026